[ad_1]
This “Single-cell analysis market size, share and trend forecasted by product (consumables, instruments), by application (IVF, cancer, stem cell), by workflow, by end use, by region and market segment, 2021-2028 analysis report” Report has been added to ResearchAndMarkets.com provide.
By 2028, the global single-cell analysis market is expected to reach 6.7 billion U.S. dollars, and is expected to grow at a compound annual growth rate of 15.0% from 2021 to 2028.
Rapid technological advancements over the years have enabled comprehensive analysis of the transcriptome and genome in a single cell.
Single-cell technology helps to assess cell heterogeneity and to analyze pathways and processes at the molecular level. With the application in oncology, immunology and other fields, this technology is developing rapidly. In addition, the introduction of advanced equipment to simplify transcriptomics and proteomics procedures is driving the market.
Advances in single-cell RNA sequencing (scRNAseq) have allowed researchers to thoroughly study rare, unexplored cell types. The development of microfluidic methods has significantly broadened the implementation of single-cell genome/transcriptomics analysis in the field of biomedicine. A large number of microfluidic devices have been modified for cell dissociation and tissue digestion.
The increase in the number of research publications represents an increase in the flow of R&D investment in this market. Since R&D activities are the foundation of innovation, these investments mean the possibility of healthy growth in this market.
In addition, researchers are committed to assessing the spatial heterogeneity of gene expression profiles at the individual cell level; therefore, it is expected to promote the use of analytical consumables and instruments.
Single cell analysis market report…
The full story on Benzinga.com
[ad_2]
Source link
